Literature DB >> 27292187

Persistent Activation of NF-κB in BRCA1-Deficient Mammary Progenitors Drives Aberrant Proliferation and Accumulation of DNA Damage.

Andrea Sau1, Rosanna Lau1, Miguel A Cabrita1, Emma Nolan2, Peter A Crooks3, Jane E Visvader2, M A Christine Pratt4.   

Abstract

Human BRCA1 mutation carriers and BRCA1-deficient mouse mammary glands contain an abnormal population of mammary luminal progenitors that can form 3D colonies in a hormone-independent manner. The intrinsic cellular regulatory defect in these presumptive breast cancer precursors is not known. We have discovered that nuclear factor kappaB (NF-κB) (p52/RelB) is persistently activated in a subset of BRCA1-deficient mammary luminal progenitors. Hormone-independent luminal progenitor colony formation required NF-κB, ataxia telangiectasia-mutated (ATM), and the inhibitor of kappaB kinase, IKKα. Progesterone (P4)-stimulated proliferation resulted in a marked enhancement of DNA damage foci in Brca1(-/-) mouse mammary. In vivo, NF-κB inhibition prevented recovery of Brca1(-/-) hormone-independent colony-forming cells. The majority of human BRCA1(mut/+) mammary glands showed marked lobular expression of nuclear NF-κB. We conclude that the aberrant proliferative capacity of Brca1(-/-) luminal progenitor cells is linked to the replication-associated DNA damage response, where proliferation of mammary progenitors is perpetuated by damage-induced, autologous NF-κB signaling.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27292187      PMCID: PMC6850408          DOI: 10.1016/j.stem.2016.05.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  56 in total

1.  WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Authors:  Joanne Chew; Subhra Biswas; Sathyavageeswaran Shreeram; Mahathir Humaidi; Ee Tsin Wong; Manprit Kaur Dhillion; Hsiangling Teo; Amit Hazra; Cheok Chit Fang; Eduardo López-Collazo; Dmitry V Bulavin; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2009-04-19       Impact factor: 28.824

2.  Signals from the nucleus: activation of NF-kappaB by cytosolic ATM in the DNA damage response.

Authors:  Kamyar Hadian; Daniel Krappmann
Journal:  Sci Signal       Date:  2011-01-18       Impact factor: 8.192

Review 3.  BRCA1--conductor of the breast stem cell orchestra: the role of BRCA1 in mammary gland development and identification of cell of origin of BRCA1 mutant breast cancer.

Authors:  Niamh E Buckley; Paul B Mullan
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

4.  Progesterone induces adult mammary stem cell expansion.

Authors:  Purna A Joshi; Hartland W Jackson; Alexander G Beristain; Marco A Di Grappa; Patricia A Mote; Christine L Clarke; John Stingl; Paul D Waterhouse; Rama Khokha
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

5.  IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain.

Authors:  H Sakurai; H Chiba; H Miyoshi; T Sugita; W Toriumi
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

6.  Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation.

Authors:  Courtney M Williams; Adam J Engler; R Daniel Slone; Leontine L Galante; Jean E Schwarzbauer
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ.

Authors:  Whitney Barham; Lianyi Chen; Oleg Tikhomirov; Halina Onishko; Linda Gleaves; Thomas P Stricker; Timothy S Blackwell; Fiona E Yull
Journal:  BMC Cancer       Date:  2015-09-30       Impact factor: 4.430

8.  Haploinsufficiency for BRCA1 leads to cell-type-specific genomic instability and premature senescence.

Authors:  Maja Sedic; Adam Skibinski; Nelson Brown; Mercedes Gallardo; Peter Mulligan; Paula Martinez; Patricia J Keller; Eugene Glover; Andrea L Richardson; Janet Cowan; Amanda E Toland; Krithika Ravichandran; Harold Riethman; Stephen P Naber; Anders M Näär; Maria A Blasco; Philip W Hinds; Charlotte Kuperwasser
Journal:  Nat Commun       Date:  2015-06-24       Impact factor: 14.919

9.  BRCA1 haploinsufficiency for replication stress suppression in primary cells.

Authors:  Shailja Pathania; Sangeeta Bade; Morwenna Le Guillou; Karly Burke; Rachel Reed; Christian Bowman-Colin; Ying Su; David T Ting; Kornelia Polyak; Andrea L Richardson; Jean Feunteun; Judy E Garber; David M Livingston
Journal:  Nat Commun       Date:  2014-11-17       Impact factor: 14.919

10.  Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.

Authors:  Mona Shehata; Andrew Teschendorff; Gemma Sharp; Nikola Novcic; I Alasdair Russell; Stefanie Avril; Michael Prater; Peter Eirew; Carlos Caldas; Christine J Watson; John Stingl
Journal:  Breast Cancer Res       Date:  2012-10-22       Impact factor: 6.466

View more
  37 in total

1.  Chromatin Remodeling in Response to BRCA2-Crisis.

Authors:  Joshua J Gruber; Justin Chen; Benjamin Geller; Natalie Jäger; Andrew M Lipchik; Guangwen Wang; Allison W Kurian; James M Ford; Michael P Snyder
Journal:  Cell Rep       Date:  2019-08-20       Impact factor: 9.423

2.  Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.

Authors:  Hua Wang; Dongxi Xiang; Ben Liu; Aina He; Helena J Randle; Kelvin Xi Zhang; Anushka Dongre; Norman Sachs; Allison P Clark; Luwei Tao; Qing Chen; Vladimir V Botchkarev; Ying Xie; Ning Dai; Hans Clevers; Zhe Li; David M Livingston
Journal:  Cell       Date:  2019-06-27       Impact factor: 41.582

3.  BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.

Authors:  H N Hilton; L J Patterson McDonald; N Santucci; F R van der Bent; A Silvestri; J D Graham; C L Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-05-18       Impact factor: 2.673

4.  LncRNA AC245100.4 binds HSP90 to promote the proliferation of prostate cancer.

Authors:  Rongjun Cui; Chi Liu; Ping Lin; Hui Xie; Wei Wang; Jiabin Zhao; Shan Jiang; Jie Shi; Xiaoguang Yu
Journal:  Epigenomics       Date:  2020-08-19       Impact factor: 4.778

5.  Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.

Authors:  Amar Hekmat Mahdi; Yanying Huo; Yongmei Tan; Srilatha Simhadri; Gabriele Vincelli; Jie Gao; Shridar Ganesan; Bing Xia
Journal:  Cancer Res       Date:  2018-05-08       Impact factor: 12.701

Review 6.  Progesterone and Breast Cancer.

Authors:  Britton Trabert; Mark E Sherman; Nagarajan Kannan; Frank Z Stanczyk
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

7.  N-[11CH3]Dimethylaminoparthenolide (DMAPT) uptake into orthotopic 9LSF glioblastoma tumors in the rat.

Authors:  Narsimha Reddy Penthala; Venumadhav Janganati; Terri L Alpe; Scott M Apana; Marc S Berridge; Peter A Crooks; Michael J Borrelli
Journal:  Bioorg Med Chem Lett       Date:  2016-11-09       Impact factor: 2.823

Review 8.  Not all cancers are created equal: Tissue specificity in cancer genes and pathways.

Authors:  Joy J Bianchi; Xin Zhao; Joseph C Mays; Teresa Davoli
Journal:  Curr Opin Cell Biol       Date:  2020-02-21       Impact factor: 8.382

9.  Homology-Directed Repair and the Role of BRCA1, BRCA2, and Related Proteins in Genome Integrity and Cancer.

Authors:  Chun-Chin Chen; Weiran Feng; Pei Xin Lim; Elizabeth M Kass; Maria Jasin
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

10.  Pharmacological Dual Inhibition of Tumor and Tumor-Induced Functional Limitations in a Transgenic Model of Breast Cancer.

Authors:  Ruizhong Wang; Poornima Bhat-Nakshatri; Maria B Padua; Mayuri S Prasad; Manjushree Anjanappa; Max Jacobson; Courtney Finnearty; Victoria Sefcsik; Kyle McElyea; Rachael Redmond; George Sandusky; Narsimha Penthala; Peter A Crooks; Jianguo Liu; Teresa Zimmers; Harikrishna Nakshatri
Journal:  Mol Cancer Ther       Date:  2017-10-04       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.